Inventor
Manuel Zancanella
Inventor
San Mateo, CA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds15%
C07BGeneral methods of organic chemistry10%
PatentTitleYear
11,111,243Azaindole compounds as histone methyltransferase inhibitors202110,836,779Compounds that inhibit MCL-1 protein202010,144,746Bridged bicyclic kallikrein inhibitors201810,100,063Compounds that inhibit Mcl-1 protein20189,815,853'Bridged bicyclic kallikrein inhibitors'20179,562,061'Compounds that inhibit MCL-1 protein'20178,258,321'Beta-lactone compounds'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012Patents assigned to BURNHAM INST MEDICAL RESEARCH (1)· patent assignee history
2012Patents assigned to MA GIL (1)· patent assignee history
2012Patents assigned to ROMO DANIEL (1)· patent assignee history
2012Based in College Station, TX, US· patent location history
2017–2020Patents assigned to AMGEN INC (3)· patent assignee history
2017–2021Patents assigned to GLOBAL BLOOD THERAPEUTICS INC (3)· patent assignee history
2017–2021Based in San Mateo, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 3 | 2017–2020 |
| GLOBAL BLOOD THERAPEUTICS INC | 3 | 2017–2021 |
| BURNHAM INST MEDICAL RESEARCH | 1 | 2012 |
| MA GIL | 1 | 2012 |
| ROMO DANIEL | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Mateo, California, US | 6 | 2017–2021 |
| College Station, Texas, US | 1 | 2012 |